'Allocation Concealment': the Evolution and Adoption of a Methodological Term

Overview

Journal J R Soc Med

Specialty General Medicine

Date 2018 Jun 8

PMID 29877772

Citations 5

Authors

Kenneth F Schulz

I Chalmers

D G Altman

D A Grimes

D Moher

R J Hayes

Affiliations

Soon will be listed here.

Citing Articles

Efficacy of mHealth Interventions for Improving the Pain and Disability of Individuals With Chronic Low Back Pain: Systematic Review and Meta-Analysis.

de Melo Santana B, Moura J, de Toledo A, Burke T, Probst L, Pasinato F JMIR Mhealth Uhealth. 2023; 11:e48204.

PMID: 37962085 PMC: 10662677. DOI: 10.2196/48204.

Neuroprotective effect of Dl-3-n-butylphthalide against ischemia-reperfusion injury is mediated by ferroptosis regulation the SLC7A11/GSH/GPX4 pathway and the attenuation of blood-brain barrier disruption.

Xu S, Li X, Li Y, Li X, Lv E, Zhang X Front Aging Neurosci. 2023; 15:1028178.

PMID: 36909944 PMC: 9995665. DOI: 10.3389/fnagi.2023.1028178.

Who knew? The misleading specificity of "double-blind" and what to do about it.

Lang T, Stroup D Trials. 2020; 21(1):697.

PMID: 32758278 PMC: 7409478. DOI: 10.1186/s13063-020-04607-5.

Doug Altman's legacy to Cochrane and evidence synthesis.

Deeks J, Hopewell S, Moher D, Higgins J, Moons K, Chandler J Cochrane Database Syst Rev. 2018; 8:ED000127.

PMID: 30221350 PMC: 10284314. DOI: 10.1002/14651858.ED000127.

How to fund the NHS.

Abbasi K J R Soc Med. 2018; 111(6):187.

PMID: 29877775 PMC: 6022890. DOI: 10.1177/0141076818782032.

References

Chan A, Altman D . Epidemiology and reporting of randomised trials published in PubMed journals. Lancet. 2005; 365(9465):1159-62. DOI: 10.1016/S0140-6736(05)71879-1. View

Peters J, Stegeman I, Grolman W, Hooft L . The risk of bias in randomized controlled trials in otorhinolaryngology: hardly any improvement since 1950. BMC Ear Nose Throat Disord. 2017; 17:3. PMC: 5395869. DOI: 10.1186/s12901-017-0036-x. View

Reveiz L, Chapman E, Asial S, Munoz S, Bonfill X, Alonso-Coello P . Risk of bias of randomized trials over time. J Clin Epidemiol. 2015; 68(9):1036-45. DOI: 10.1016/j.jclinepi.2014.06.001. View

. A proposal for structured reporting of randomized controlled trials. The Standards of Reporting Trials Group. JAMA. 1994; 272(24):1926-31. View

Altman D, Schulz K, Moher D, Egger M, Davidoff F, Elbourne D . The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med. 2001; 134(8):663-94. DOI: 10.7326/0003-4819-134-8-200104170-00012. View

Tyson J, Furzan J, Reisch J, Mize S . An evaluation of the quality of therapeutic studies in perinatal medicine. J Pediatr. 1983; 102(1):10-3. DOI: 10.1016/s0022-3476(83)80277-7. View

Chan A, Tetzlaff J, Gotzsche P, Altman D, Mann H, Berlin J . SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013; 346:e7586. PMC: 3541470. DOI: 10.1136/bmj.e7586. View

Schulz K, Chalmers I, Altman D, Grimes D, Dore C . The methodologic quality of randomization as assessed from reports of trials in specialist and general medical journals. Online J Curr Clin Trials. 1995; Doc No 197:[81 paragraphs]. View

Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I . Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA. 1996; 276(8):637-9. DOI: 10.1001/jama.276.8.637. View

10.

Moher D, Pham B, Jones A, Cook D, Jadad A, Moher M . Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?. Lancet. 1998; 352(9128):609-13. DOI: 10.1016/S0140-6736(98)01085-X. View

11.

Sterne J, Juni P, Schulz K, Altman D, Bartlett C, Egger M . Statistical methods for assessing the influence of study characteristics on treatment effects in 'meta-epidemiological' research. Stat Med. 2002; 21(11):1513-24. DOI: 10.1002/sim.1184. View

12.

Devereaux P, Manns B, Ghali W, Quan H, Lacchetti C, Montori V . Physician interpretations and textbook definitions of blinding terminology in randomized controlled trials. JAMA. 2001; 285(15):2000-3. DOI: 10.1001/jama.285.15.2000. View

13.

Conti C . Confusing and sometimes meaningless terms used in cardiovascular medicine. Clin Cardiol. 1994; 17(2):53-4. View

14.

Schulz K, Altman D, Moher D, Fergusson D . CONSORT 2010 changes and testing blindness in RCTs. Lancet. 2010; 375(9721):1144-6. DOI: 10.1016/S0140-6736(10)60413-8. View

15.

Juni P, Egger M . Commentary: Empirical evidence of attrition bias in clinical trials. Int J Epidemiol. 2005; 34(1):87-8. DOI: 10.1093/ije/dyh406. View

16.

Turner L, Shamseer L, Altman D, Schulz K, Moher D . Does use of the CONSORT Statement impact the completeness of reporting of randomised controlled trials published in medical journals? A Cochrane review. Syst Rev. 2012; 1:60. PMC: 3564748. DOI: 10.1186/2046-4053-1-60. View

17.

CHALMERS T, Celano P, Sacks H, SMITH Jr H . Bias in treatment assignment in controlled clinical trials. N Engl J Med. 1983; 309(22):1358-61. DOI: 10.1056/NEJM198312013092204. View

18.

Altman D, Dore C . Randomisation and baseline comparisons in clinical trials. Lancet. 1990; 335(8682):149-53. DOI: 10.1016/0140-6736(90)90014-v. View

19.

Schulz K, Grimes D . Blinding in randomised trials: hiding who got what. Lancet. 2002; 359(9307):696-700. DOI: 10.1016/S0140-6736(02)07816-9. View

20.

Schulz K, Altman D, Moher D . CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010; 340:c332. PMC: 2844940. DOI: 10.1136/bmj.c332. View